Prelude Therapeutics Inc. is a biopharmaceutical company focused on the discovery and development of new small molecule therapeutics targeting critical cancer and rare disease pathways.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!